Rick Doblin

Date: 2016-04-07 | Duration: 2h 39m

Episode Overview

Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), shares deep insights into the evolving landscape of psychedelic research and therapy. Reflecting on over 30 years of advocacy, Doblin discusses the scientific rigor behind MDMA-assisted psychotherapy for PTSD, emphasizing the importance of controlled studies that balance benefits with risks. He explains how MDMA reduces fear responses, allowing patients to revisit traumatic memories with greater openness and self-acceptance, which can lead to lasting healing. Doblin also highlights the challenges faced in gaining regulatory approval, including navigating FDA protocols and overcoming decades of stigma rooted in the war on drugs. Beyond MDMA, Doblin touches on the broader cultural and historical context of psychedelics, including their spiritual significance and the complexities of cultural appropriation. He recounts stories from indigenous communities and the intersections of Western and traditional practices, underscoring the need for respectful integration rather than exploitation. Additionally, Doblin addresses misconceptions about other substances like marijuana, noting the slow progress in legitimizing cannabinoid-based medicines despite widespread anecdotal support. Throughout the conversation, he stresses the transformative potential of psychedelics when combined with psychotherapy and the critical role of scientific validation in shaping future mental health treatments.

About Rick Doblin

Rick Doblin, Ph.D., is a pioneering advocate for psychedelic research and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). With a background in public policy and a Ph.D. in sociology and psychology, he has spearheaded groundbreaking clinical trials exploring the therapeutic potential of MDMA for PTSD and other mental health conditions. Doblin's work has not only contributed to shifting public perception around psychedelics but has also positioned MAPS at the forefront of a renaissance in psychedelic science, making him a captivating figure in discussions about mental health and consciousness. His insights into the intersection of psychedelics and healing continue to spark interest and debate, making him a compelling guest on platforms like the Joe Rogan Experience.

Key Moments

– Psychedelic Therapy
– MDMA Research
– PTSD Treatment
– Drug Policy Reform
– Psychedelic Science
– Cultural Appropriation
– Clinical Trials
– Neuropharmacology
– Psychedelic Integration
– FDA Regulation
– Historical Drug Use
– Addiction and Recovery
– Mental Health
– Psychedelic Safety
– Indigenous Traditions
– Psychedelic Medicine
– Research Methodology
– Psychedelic Effects
– Public Perception
– Therapeutic Outcomes
0:00:41 – Introduction and meeting with Ralph Metzner
0:03:57 – Celebrating 30 years of MAPS foundation
0:06:14 – Honest sharing of psychedelic experiences
0:07:38 – Discussion on marijuana and cannabinoids
0:10:21 – Effects of psychedelics on perception and performance
0:11:59 – Balancing risks and benefits of psychedelics
0:13:00 – Handling anxiety during intense psychedelic experiences
0:15:31 – Affidavits and personal testimonies on psychedelics
0:17:51 – Imagining interplanetary travel and cultural observations
0:21:58 – Unsettling truths about cultural identity
0:28:17 – Cultural appropriation debates in food and fashion
0:33:41 – Creative writing and productivity techniques
0:40:31 – MAPS use of social media and outreach
0:42:17 – Impact of assisted psychotherapy with MDMA
0:48:15 – Dose response and patient outcomes in MDMA trials
0:53:13 – MDMA reducing fear response in trauma therapy
0:56:35 – MDMA promotes openness, self-acceptance, and love
1:03:08 – First couple therapy study using MDMA
1:07:03 – MDMA as a general therapeutic tool
1:16:14 – Origins and impact of the drug war
1:18:17 – Brain chemistry and drug labeling challenges
1:22:26 – Development of MDMA molecule from methamphetamine and mescaline
1:24:56 – History of LSD and Albert Hofmann's discovery
1:31:04 – Historical perspectives on Columbus and indigenous peoples
1:41:56 – Cultural appropriation versus integration in psychedelics
1:48:38 – Religious exemptions and psychedelic use
1:53:53 – Scientific data supporting psychedelic therapy
1:57:17 – Scientific approach to drug laws and protections
2:01:40 – Ego dissolution and boundary breaking in therapy
2:04:01 – Veterans' experiences with MDMA and ecstasy
2:07:56 – Marijuana research challenges and progress
2:13:14 – DEA lawsuit and regulatory hurdles
2:16:52 – Insurance and FDA approval for psychedelic medicines
2:21:56 – Motivation for involvement in MDMA research
2:25:59 – Potential of psychedelics to reduce war and conflict
2:32:41 – Importance of integration after psychedelic experiences

Transcript Excerpt

Starting point is 00:00:00 the call is that okay is that comfortable yeah okay Starting point is 00:00:41 yeah and actually i was just um yesterday yesterday and today with Ralph Metzner, Starting point is 00:01:13 when it comes to the the dialogue of psychedelics because from an outsider this is how i always view Starting point is 00:01:51 Because there's not a lot of people that – that's one of the weird things about psychedelics. Starting point is 00:02:36 So people don't really know who in society has had these influences. Starting point is 00:03:10 Oh, good Lord. Starting point is 00:03:30 Well, we're in these camps, you know, we have these camps, the do's and don'ts. Starting point is 00:03:57 Actually, tomorrow is the 30th year that I started MAPS in 1986. Starting point is 00:04:31 There's with conversations about death with dinner and drugs with dinner even. Starting point is 00:04:59 And so people can write in and just say psychedelics matter to me because or you know i i'm more hopeful or i'm Starting point is 00:05:50 and that people have made lives out of them, Starting point is 00:06:14 being really honest about their experiences Starting point is 00:06:34 whether you're a right wing or a left wing, Starting point is 00:06:56 And you lock their, like, people. Starting point is 00:07:21 Says who? Starting point is 00:07:38 Health, about marijuana and cannabinoids. Starting point is 00:08:09 you're not going to do a whole lot of thinking. Starting point is 00:08:30 Like you shouldn't say, you know, I'm just going to be high from the moment I wake up Starting point is 00:08:49 And I enjoyed it. Starting point is 00:09:06 while I was stoned. Starting point is 00:09:23 Isn't that hilarious? Starting point is 00:09:35 They say that it's one of the things about the NBA. Starting point is 00:10:01 but there's a video of me doing an impression of him. Starting point is 00:10:21 You have a better sense of where the ball's going. Starting point is 00:10:55 There ...

More Episodes

Frequently asked about this episode

Who was the guest on Joe Rogan Experience #782?

Rick Doblin was the guest on JRE #782. This page includes the episode overview, topics discussed, and related resources.

What topics were discussed on JRE #782?

On Joe Rogan Experience #782 with Rick Doblin, topics include Psychedelic Therapy, MDMA Research, PTSD Treatment, and Drug Policy Reform.

Where can I read the transcript for JRE #782?

The full searchable transcript for Joe Rogan Experience #782 with Rick Doblin is available on this page, along with key topics and timestamps.